Cargando…

The growth feature and its diagnostic value for benign and malignant pulmonary nodules met in routine clinical practice

BACKGROUND: Growth rate is an independent risk factor for lung cancer in screened pulmonary nodules. This study aimed to clarify growth characteristics of pulmonary nodules in routine clinical practice and examine whether volume doubling time (VDT) can predict the malignancy of these nodules. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Rui, Tian, Panwen, Qiu, Zhixin, Liang, Yiying, Li, Weimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330364/
https://www.ncbi.nlm.nih.gov/pubmed/32642104
http://dx.doi.org/10.21037/jtd-19-3591
_version_ 1783553104654893056
author Zhang, Rui
Tian, Panwen
Qiu, Zhixin
Liang, Yiying
Li, Weimin
author_facet Zhang, Rui
Tian, Panwen
Qiu, Zhixin
Liang, Yiying
Li, Weimin
author_sort Zhang, Rui
collection PubMed
description BACKGROUND: Growth rate is an independent risk factor for lung cancer in screened pulmonary nodules. This study aimed to clarify growth characteristics of pulmonary nodules in routine clinical practice and examine whether volume doubling time (VDT) can predict the malignancy of these nodules. METHODS: We retrospectively enrolled patients with 5–30-mm-sized pulmonary nodules that had been surgically resected after a follow-up of at least 3 months. Two follow-up computed tomography (CT) images with similar thickness and long interval were obtained. Then, three-dimensional (3D) manual segmentation for all nodules was performed on two follow-up CT scans. Subsequently, VDT was calculated for nodules with a change in volume of at least 25%. RESULTS: Overall, 305 pulmonary nodules in 305 patients (men, 36.7%; median age, 57) were included. The mean increased diameter, mass, and volume of benign (n=86) and malignant (n=219) nodules were 0.09 vs. 2.37 mm, 0.10 vs. 0.66 g, and 32.74 vs. 1,871.28 mm3, respectively (P<0.05). In total, 24 of 86 benign nodules (28%, 18 grew and 6 shrank) and 121 of 219 malignant nodules (55%, 114 grew and 7 shrank) changed over time. The median VDTs of growing benign and malignant nodules were 389 and 526 days, respectively, (P=0.18), and the area under the receiver operating characteristic (ROC) curve was 0.67 (0.55–0.78), with a sensitivity and specificity of 69% and 58%, respectively. The median VDT for growing nodules was 339 days for inflammatory pseudotumors, 226 days for granulomas, 640 days for benign tumors, 1,541 days for enlarged lymph nodes, 762 days for adenocarcinoma in situ, 954 days for microinvasive adenocarcinoma, 534 days for invasive adenocarcinoma, and 118 days for squamous cell carcinoma. CONCLUSIONS: In routine clinical practice, many malignant nodules could grow slowly or even remain stable over time. Regarding growing nodules, the diagnostic value of VDT was limited.
format Online
Article
Text
id pubmed-7330364
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-73303642020-07-07 The growth feature and its diagnostic value for benign and malignant pulmonary nodules met in routine clinical practice Zhang, Rui Tian, Panwen Qiu, Zhixin Liang, Yiying Li, Weimin J Thorac Dis Original Article BACKGROUND: Growth rate is an independent risk factor for lung cancer in screened pulmonary nodules. This study aimed to clarify growth characteristics of pulmonary nodules in routine clinical practice and examine whether volume doubling time (VDT) can predict the malignancy of these nodules. METHODS: We retrospectively enrolled patients with 5–30-mm-sized pulmonary nodules that had been surgically resected after a follow-up of at least 3 months. Two follow-up computed tomography (CT) images with similar thickness and long interval were obtained. Then, three-dimensional (3D) manual segmentation for all nodules was performed on two follow-up CT scans. Subsequently, VDT was calculated for nodules with a change in volume of at least 25%. RESULTS: Overall, 305 pulmonary nodules in 305 patients (men, 36.7%; median age, 57) were included. The mean increased diameter, mass, and volume of benign (n=86) and malignant (n=219) nodules were 0.09 vs. 2.37 mm, 0.10 vs. 0.66 g, and 32.74 vs. 1,871.28 mm3, respectively (P<0.05). In total, 24 of 86 benign nodules (28%, 18 grew and 6 shrank) and 121 of 219 malignant nodules (55%, 114 grew and 7 shrank) changed over time. The median VDTs of growing benign and malignant nodules were 389 and 526 days, respectively, (P=0.18), and the area under the receiver operating characteristic (ROC) curve was 0.67 (0.55–0.78), with a sensitivity and specificity of 69% and 58%, respectively. The median VDT for growing nodules was 339 days for inflammatory pseudotumors, 226 days for granulomas, 640 days for benign tumors, 1,541 days for enlarged lymph nodes, 762 days for adenocarcinoma in situ, 954 days for microinvasive adenocarcinoma, 534 days for invasive adenocarcinoma, and 118 days for squamous cell carcinoma. CONCLUSIONS: In routine clinical practice, many malignant nodules could grow slowly or even remain stable over time. Regarding growing nodules, the diagnostic value of VDT was limited. AME Publishing Company 2020-05 /pmc/articles/PMC7330364/ /pubmed/32642104 http://dx.doi.org/10.21037/jtd-19-3591 Text en 2020 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Zhang, Rui
Tian, Panwen
Qiu, Zhixin
Liang, Yiying
Li, Weimin
The growth feature and its diagnostic value for benign and malignant pulmonary nodules met in routine clinical practice
title The growth feature and its diagnostic value for benign and malignant pulmonary nodules met in routine clinical practice
title_full The growth feature and its diagnostic value for benign and malignant pulmonary nodules met in routine clinical practice
title_fullStr The growth feature and its diagnostic value for benign and malignant pulmonary nodules met in routine clinical practice
title_full_unstemmed The growth feature and its diagnostic value for benign and malignant pulmonary nodules met in routine clinical practice
title_short The growth feature and its diagnostic value for benign and malignant pulmonary nodules met in routine clinical practice
title_sort growth feature and its diagnostic value for benign and malignant pulmonary nodules met in routine clinical practice
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330364/
https://www.ncbi.nlm.nih.gov/pubmed/32642104
http://dx.doi.org/10.21037/jtd-19-3591
work_keys_str_mv AT zhangrui thegrowthfeatureanditsdiagnosticvalueforbenignandmalignantpulmonarynodulesmetinroutineclinicalpractice
AT tianpanwen thegrowthfeatureanditsdiagnosticvalueforbenignandmalignantpulmonarynodulesmetinroutineclinicalpractice
AT qiuzhixin thegrowthfeatureanditsdiagnosticvalueforbenignandmalignantpulmonarynodulesmetinroutineclinicalpractice
AT liangyiying thegrowthfeatureanditsdiagnosticvalueforbenignandmalignantpulmonarynodulesmetinroutineclinicalpractice
AT liweimin thegrowthfeatureanditsdiagnosticvalueforbenignandmalignantpulmonarynodulesmetinroutineclinicalpractice
AT zhangrui growthfeatureanditsdiagnosticvalueforbenignandmalignantpulmonarynodulesmetinroutineclinicalpractice
AT tianpanwen growthfeatureanditsdiagnosticvalueforbenignandmalignantpulmonarynodulesmetinroutineclinicalpractice
AT qiuzhixin growthfeatureanditsdiagnosticvalueforbenignandmalignantpulmonarynodulesmetinroutineclinicalpractice
AT liangyiying growthfeatureanditsdiagnosticvalueforbenignandmalignantpulmonarynodulesmetinroutineclinicalpractice
AT liweimin growthfeatureanditsdiagnosticvalueforbenignandmalignantpulmonarynodulesmetinroutineclinicalpractice